However, B2M plasma levels are commonly elevated in patients with chronic kidney disease (CKD) as a result of decreased glomerular filtration rate (GFR) [18] and the CLL-IPI risk model was not adjusted for compromised renal function [11,13]. Here, B2M is linked to chronic kidney disease.